Transcript for Yankee Stadium, Disneyland transform into COVID-19 vaccine mega-sites
story, the latest on the covid-19 emergency. The U.S. Reporting more than 10 million people have received their first dose of the vaccine. That's out of the 29 million doses that have been distributed so far. This as more vaccine megasites are gearing up to help. Stephanie Ramos has the latest. Reporter: A stark new warning in the battle. A white house coronavirus task force report obtained by ABC news stating all metro areas over 500,000 are in full resurgence. More dying from the virus than who died from the flu last year. We got an inside look at a field hospital re-opened at a convention center to handle the surge of patients. There is an entire operation setup on this convention floor. Patient rooms set up throughout to treat more than 200 covid patients. The vaccine rollout slowly ramping up. Mass vaccination sites opening including Yankee stadium and disneyland in California. Today for many getting vaccinated it is truly the happiest place on Earth. Reporter: Only 10.3 million have received the first dose of the vaccine. Just 10% of the prioritized population and only 3% of the entire country. In Mississippi, the department of health says it has now committed their entire vaccine supply and not expected to get more until next month. New York City also running low. We will run out of vaccine at some point next week unless we get a major new resupply. Reporter: California and new Jersey opening up vaccinations to people 65 and over. New Jersey offering the vaccine to those with pre-existing conditions including smokers. Smoking puts you at significant risk for an adverse reresult from covid-19 and there are 2 million smokers in new Jersey that fit into this category. Reporter: And now a new concern. Researchers at Ohio state university identifying two new variants here in the U.S. That are not related to international travel. The presence of new virus mutations always raises the possibility of evading either the immunity from prior infections or immunity from vaccination. To date we have no evidence that there's any risk of failure to respond to vaccines. Reporter: Johnson & Johnson is expecting results from their phase 3 trial by the end of January. If it's proven to be safe and effective, Johnson & Johnson's single dose vaccine could be authorized by mid-february. With millions of doses ready to go. Michael. A lot of people excited about thank you so much.
This transcript has been automatically generated and may not be 100% accurate.